The UK national study of magnetic resonance imaging as a method of screening for breast cancer (MARIBS)

Magnetic Resonance Imaging as a Method of Screening for Breast Cancer Advisory Group, M O Leach, R A Eeles, L W Turnbull, A K Dixon, J Brown, R J C Hoff, A Coulthard, J M Dixon, D F Easton, D G R Evans, F J Gilbert, J Hawnaur, C Hayes, P Kessar, S Lakhani, G Liney, S M Moss, A P Padhani, L J PointonM Sydenham, L G Walker, R M L Warren, N E Haites, P Morrison, T Cole, Z Rayter, A Donaldson, M Shere, J Rankin, D Goudie, C M Steel, R Davidson, C Chu, I Ellis, J Mackay, S V Hodgson, T Homfray, F Douglas, O W Quarrell, D M Eccles, F G Gilbert, G Crothers, C P Walker, A Jones, N Slack, P Britton, D G Sheppard, J Walsh, G Whitehouse, W Teh

Research output: Contribution to journalArticlepeer-review

Abstract / Description of output

The UK national study of magnetic resonance imaging as a method of screening for breast cancer (MARIBS) is in progress. The study design, accrual to date, and related research projects are described. Revised accrual rates and expected recruitment are given. 15 cancers have been detected to date, from a total of 1236 screening measurements. This event rate and the tumour grades reported are compared with recent reports from other studies in women at high risk of breast cancer.
Original languageEnglish
Pages (from-to)107-14
Number of pages8
JournalJournal of experimental & clinical cancer research : CR
Volume21
Issue number3 Suppl
Publication statusPublished - Sept 2002

Keywords / Materials (for Non-textual outputs)

  • Adult
  • Breast Neoplasms
  • Cohort Studies
  • Female
  • Genes, BRCA1
  • Genes, BRCA2
  • Genetic Predisposition to Disease
  • Humans
  • Image Processing, Computer-Assisted
  • Magnetic Resonance Imaging
  • Mammography
  • Mass Screening
  • Middle Aged
  • Mutation
  • Patient Selection
  • Quality Control
  • Sensitivity and Specificity

Fingerprint

Dive into the research topics of 'The UK national study of magnetic resonance imaging as a method of screening for breast cancer (MARIBS)'. Together they form a unique fingerprint.

Cite this